Scientific Advisory Board

Noubar Afeyan, Ph.D., Founder and CEO, Flagship Pioneering

Houman Ashrafian, D.Phil., Managing Partner, SV Health Investors

Bruce Booth, D.Phil., Partner, Atlas Venture

Mark Currie, Ph.D., President and CSO, Cyclerion Therapeutics Inc.

Francis Cuss, M.D., (former) EVP and CSO, R&D, Bristol-Myers Squibb Co.

Francesco de Rubertis, Ph.D., Co-founder and Partner, Medicxi

Susan Dillon, Ph.D., Co-Founder, President and CEO of Aro Biotherapeutics Co.

Todd Foley, Managing Director, MPM Capital

Carol Gallagher, Pharm.D., Partner, New Enterprise Associates

Laurie Glimcher, M.D., President and CEO, Dana-Farber Cancer Institute

Michael Hayden, M.D., Ph.D., (former) President Global R&D, CSO, Teva Pharmaceutical Industries Ltd.

Kewen Jin, M.D., Managing Partner, Serica Partners

Sophie Kornowski, Ph.D., Senior Partner, Gurnet Point Capital

Iya Khalil, Ph.D., Chief Commercial Officer and Co-Founder, GNS Healthcare Inc.

Reid Huber, Ph.D., Partner, Third Rock Ventures

Menelas Pangalos, Ph.D., EVP, BioPharmaceuticals R&D, AstraZeneca plc

Antoine Papiernik, Managing Partner, Sofinnova Partners

Kush Parmar, M.D., Ph.D., Managing Partner, 5AM Ventures

Cary Pfeffer, M.D., Partner, Third Rock Ventures

Andrew Plump, M.D., Ph.D., President of R&D, Takeda Pharmaceutical Co. Ltd.

Otello Stampacchia, Ph.D., Founder and Managing Director, Omega Funds

Paul-Peter Tak, M.D., Ph.D., Venture Partner, Flagship Pioneering, CEO, Kintai Therapeutics Inc.

Helen Tayton-Martin, Ph.D., CBO, Adaptimmune Ltd.

James Sabry, M.D., Ph.D., Global Head of Pharma Partnering, Roche

Marc Tessier-Lavigne, Ph.D., President, Stanford University

Jan van de Winkel, Ph.D., President and CEO, Genmab A/S

Keith Yamamoto, Ph.D., Vice Chancellor, Science Policy and Strategy, University of California San Francisco

Douglas Williams, Ph.D., Co-founder, President and CEO, Codiak BioSciences Inc.

Elias Zerhouni, M.D., (former) President, Global R&D, Sanofi